# DISCOVERY — Pain Point Board
## AnyCompany Clinical Consultation Workflow

**Date:** 2026-07-08  
**Participant:** Jordan Lee (JL), Senior Solutions Architect, AWS  
**Mode:** Deep Discovery  
**Space:** AnyCompanyClinicalConsultation-v1  

---

## Executive Summary

Discovery identified **7 pain points** across 3 categories affecting AnyCompany's clinical consultation workflow. The current 4-system architecture (UI → Integration Layer → AnyCompanyEMR + AnyCompany Insight AI) creates fragmentation, opacity, and error-prone manual processes that directly impact patient outcomes. Multiple solution areas identified — pipeline proceeds to **Prioritize** stage.

---

## Business Context

| Dimension | Detail |
|-----------|--------|
| **Industry** | Healthcare / Clinical Decision Support |
| **Architecture** | 4-system: Clinical UI → Integration Layer → AnyCompanyEMR + AnyCompany Insight AI |
| **Markets** | United States + European Union |
| **Target Users** | Physicians and Clinicians |
| **AI Component** | AnyCompany Insight AI (clinical guidelines & recommendations) |
| **Integration Model** | Legacy monolithic integration layer |

---

## Category 1: Clinical Workflow

| # | Pain Point | Severity | Frequency | Patient Impact | Regulatory |
|---|-----------|----------|-----------|----------------|------------|
| 1 | **Fragmented workflow** — Physicians must navigate multiple disconnected systems during consultations | 8/10 | Daily | Delayed care, cognitive burden reduces diagnostic accuracy | HIPAA (data traversing multiple systems) |
| 2 | **No real-time guideline evaluation** — Clinical guidelines not surfaced at point of care | 9/10 | Daily | Missed diagnoses, outdated protocols applied | HIPAA, GDPR (patient data used for AI inference) |
| 5 | **Separate order placement** — Orders placed in a different system from where clinical decisions are made | 7/10 | Daily | Delayed treatment initiation, transcription errors | HIPAA (order integrity) |
| 6 | **Error-prone manual processes** — Manual data entry and cross-system reconciliation | 9/10 | Daily | Adverse events from data entry errors, missed diagnoses | HIPAA, GDPR (data accuracy requirements) |
| 7 | **Time-consuming consultations** — Excessive time spent on system navigation vs. patient care | 7/10 | Daily | Reduced patient face-time, physician burnout | — |

## Category 2: AI/ML Transparency

| # | Pain Point | Severity | Frequency | Patient Impact | Regulatory |
|---|-----------|----------|-----------|----------------|------------|
| 3 | **Opaque AI reasoning** — AnyCompany Insight AI provides recommendations without explainable rationale | 8/10 | Daily | Physicians may distrust/ignore valid AI suggestions, or blindly follow without understanding | GDPR Art. 22 (right to explanation), EU AI Act (high-risk clinical AI) |

## Category 3: Technical Infrastructure

| # | Pain Point | Severity | Frequency | Patient Impact | Regulatory |
|---|-----------|----------|-----------|----------------|------------|
| 4 | **Legacy monolithic integration layer** — Single point of failure, difficult to extend or modernize | 7/10 | Weekly (outages/issues) | System downtime blocks clinical workflow entirely | HIPAA (availability requirements) |

---

## Market Assumptions

| Dimension | Assumption | Basis |
|-----------|-----------|-------|
| **Scale** | ~200-500 physicians across US + EU deployments | Mid-size health system with multi-geography CDS platform |
| **Volume** | ~2,000-5,000 clinical consultations/day | Average 10 consultations/physician/day |
| **Revenue Impact** | 15-25% physician churn risk if workflow friction persists | Healthcare SaaS benchmarks; clinical tool satisfaction strongly correlates with retention |
| **Cost of Inaction** | ~$2-5M annual revenue at risk from churn + $500K-1M in error remediation | Based on per-seat SaaS pricing × at-risk physician count |

---

## Regulatory Context

| Regulation | Applicability |
|-----------|--------------|
| **HIPAA** | All pain points involving PHI data flow, system availability, order integrity |
| **GDPR** | Patient data processing for AI inference, data accuracy requirements (EU market) |
| **EU AI Act** | High-risk clinical AI system — explainability and human oversight requirements |
| **GDPR Art. 22** | Right to explanation for automated clinical decisions |

---

## Key Findings

- **Highest Severity (9/10):** No real-time guideline evaluation + Error-prone manual processes
- **Broadest Impact:** Fragmented workflow (touches every consultation, every physician, every day)
- **Regulatory Risk:** GDPR/EU AI Act exposure on opaque AI reasoning (Category 2)
- **Infrastructure Debt:** Legacy monolithic integration is root cause enabling Categories 1 and 2

---

## Solution Areas Identified (→ Prioritize Stage)

| Solution Area | Addresses Pain Points | Category |
|--------------|----------------------|----------|
| **Unified Clinical Workflow** | #1, #5, #6, #7 | Clinical Workflow |
| **Real-time AI-Guided Clinical Decision Support** | #2, #3 | Clinical Workflow + AI/ML |
| **Infrastructure Modernization (Event-Driven)** | #4 (enables all) | Technical Infrastructure |

---

## Routing Decision

**Multiple solution areas identified** → Proceed to **Stage 2: Prioritize**

---

*Generated by AI-PDLC Discovery | Pipeline: AnyCompanyClinicalConsultation-v1*
